Fritextsökning
Innehållstyper
-
Dry blood DNA storage on a matrix
Qiagen recently presented a method of dry blood sample storage as an alternative to storage in freezers.
-
Faster sales but less profits for Probi
The probiotic company increases its turnover, and the net results are twice as large as last year.
-
Ny vd på Klaria
Kommer närmast från Oberland Capital.
-
Acadia drug awarded
Acadia Pharmaceutical has got an award for a new treatment against Parkinson's disease.
-
Coronaviruset – "en konspiration" enligt oväntat många amerikaner
En ny undersökning visar att en tredjedel av alla amerikaner tror att coronaviruset skapades i ett laboratorium, rapporterar The Guardian.
-
Storbritannien har godkänt injektion för viktminskning
Storbritannien börjar med läkemedel för viktminskning för personer med kraftig fetma. Hälsomyndigheten har godkänt läkemedlet Ozempic (semaglutide) från danska ...
-
EU says yes to Roche drug
EU approves a first in class therapy for treatment of patients with moderate to severe form of rheumatoid arthritis.
-
Astra Zeneca nådde inte mål i lungcancerstudie
-
Pfizer lays a chunky bid on Wyeth
The merger of two pharma giants is the largest industry deal so far this year. Pfizer will acquire Wyeth in a cash-and-stock transaction currently valued at app...
-
New firm based on SLU research
Four researchers at the Swedish University of Agricultural Sciences, SLU, has recently founded a new nanotech company.
-
"Imponerande kraftsamling gav vaccin"
Det rekordsnabba framtagandet av nya vaccin under pandemin visar vad läkemedelsindustrin – och mänskligheten – kan åstadkomma när pressen är tillräckligt stor.
-
New NO product reduces diabetic pain
The Swedish medtech company Nolabs has announced that it has achieved an important milestone in the development of a new line of products.
-
Respiratorius hunts millions
The biopharmaceutical company Respiratorius has got a new CEO, who starts a public new share issue to catch almost SEK ten million.
-
Medicult needs a word of advice
Medicult Board retains advisers, regarding the previous offer from Vitrolife.
-
Per Hammargren, Sales Director, ICU Scandinavia AB
Why are you going to Scanlab and Biotech Forum?
-
Go ahead for leg wound study
Tripep starts a phase II-study of their wound healing joint venture project.
-
Medtech companies find new beam technique
The medtech companies Raysearch and Nucletron expand collaboration with two new solutions for radiation treatment planning.
-
Biovitrum sells UK part
Biovitrum will soon spin-out a British subsidary
-
Norwegian cancer therapy leaves phase II
New clinical results from Algeta highlights the potential of Alpharadin to treat bone metastases in major cancer indications.
-
Sobis samarbete med Sanofi ger skörd – läkemedel mot hemofili godkänt i USA
Svenska särläkemedelsbolaget Sobi har fått ett nytt läkemedel mot hemofili A godkänt i USA. I EU väntas en ansökan om godkännande lämnas in senare i år.
-
Norwegian describes scrapie gene
Intestinal lymphatic tissue is important for the absorption and spread of the scrapie prion, suggests a Norwegian researcher.
-
EU godkänner ny behandling som skyddar spädbarn mot RS-virus
Astra Zeneca och Sanofi har fått sin preventiva behandling mot RS-virusinfektion hos spädbarn godkänd i EU.
-
New CEO to Promedvi
Sigrun Axelsson has taken on the leadership of the Lund-based medtech company.
-
Ny metod förutser lovande läkemedel
Enligt en ny studie kan forskningsbolaget Attanas teknik förbättra lyckandegraden för kliniska studier.